Their approach highlights how complex biological data can inform nanoparticle design for targeting neurodegenerative pathways
(1996) published the Phase I clinical study of MT-II demonstrating melanotropic activity (PMID 8637402)
Lammi, Carmen, and Anna Arnoldi
LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer
According to studies, gut microbiome dysbiosis contributes to the fast development of insulin resistance in T2D, which causes nearly 90% of all instances of diabetes globally
SLC6A14 is overexpressed in colorectal cancer (Lu et al., 2022), ER + breast cancer (Karunakaran et al., 2011), gastric cancer (Wang and Wang, 2022), pancreatic cancer (Schniers et al., 2022), and cervical cancer (Sikder et al., 2018), closely related to lower overall survival